Wedbush Securities’s Kewaunee Scientific KEQU Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q3
Sell
-3,960
Closed -$232K 1218
2025
Q2
$232K Buy
+3,960
New +$147K 0.01% 971
2025
Q1
Sell
-4,235
Closed -$262K 1147
2024
Q4
$262K Buy
+4,235
New +$172K 0.01% 888
2024
Q3
Sell
-6,560
Closed -$310K 1188
2024
Q2
$310K Sell
6,560
-1,473
-18% -$55.8K 0.01% 849
2024
Q1
$276K Sell
8,033
-175
-2% -$5.18K 0.01% 921
2023
Q4
$239K Sell
8,208
-2,213
-21% -$44.8K 0.01% 874
2023
Q3
$180K Buy
+10,421
New +$167K 0.01% 938
2023
Q2
Sell
-10,171
Closed -$157K 1104
2023
Q1
$157K Sell
10,171
-1,265
-11% -$20.1K 0.01% 975
2022
Q4
$177K Hold
11,436
0.01% 935
2022
Q3
$201K Hold
11,436
0.01% 900
2022
Q2
$190K Hold
11,436
0.01% 940
2022
Q1
$166K Sell
11,436
-492
-4% -$6.92K 0.01% 1013
2021
Q4
$151K Sell
11,928
-345
-3% -$4.41K 0.01% 1092
2021
Q3
$164K Hold
12,273
0.01% 1086
2021
Q2
$177K Buy
+12,273
New +$152K 0.01% 1079
2021
Q1
Sell
-10,190
Closed -$127K 1087
2020
Q4
$127K Hold
10,190
0.01% 819
2020
Q3
$91K Hold
10,190
0.01% 838
2020
Q2
$95K Hold
10,190
0.01% 862
2020
Q1
$81K Buy
+10,190
New +$113K 0.01% 790

Other funds holding KEQU

Wedbush Securities's KEQU Position: Q3 2025 in Review

Wedbush Securities sold out of Kewaunee Scientific (KEQU) in Q3 2025, closing a stake of 3,960 shares — an estimated $232K sold.

Wedbush Securities first reported a position in KEQU in Q1 2020 and held it in 18 quarters. The position peaked at $310K in Q2 2024. 34 funds tracked by Wall St. Rank hold KEQU as of Q3 2025.

  • Wedbush Securities reported no remaining Kewaunee Scientific position as of Q3 2025 after selling out during the quarter.
  • Wedbush Securities sold 3,960 Kewaunee Scientific shares in Q3 2025, an estimated $232K.
  • Wedbush Securities first reported a position in Kewaunee Scientific in Q1 2020 and held it in 18 quarters.
  • Wedbush Securities's Kewaunee Scientific position peaked at $310K in Q2 2024.
  • 34 funds tracked by Wall St. Rank held Kewaunee Scientific as of Q3 2025.

Based on Wedbush Securities's 13F filing for Q3 2025, filed 6 Nov 2025.